Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Biotech ETF (XBI)

Delayed Data
As of Feb 12
 +1.32 / +2.89%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.


1 month-19.71% 3 years+15.00%
3 months-30.69% 5 years+18.30%
1 year-29.45% Since inception+11.45%
Data through 02/13/2016

Quote Details

Previous close$45.73
Open day’s range44.88 – 47.19
Net asset value (NAV)47.19 (02/12/2016)
Daily volume6,210,711
Average volume (3 months)5,679,886
Data as of 3:59pm ET, 02/12/2016

Peer Comparisonvs. Health ETFs

Performance 5-yr return+18.30%+20.72%
Expense Gross exp ratio0.35%0.47%
Risk 5 year sharpe ratio0.771.06
Net assets$1.5B$1.4B
Average market cap$2.6B$36.5B
Average P/E--22.4
Dividend / Share--0.22%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
BXLT Baxalta Inc2.16%
ABBV AbbVie2.03%
AMGN Amgen1.97%
XON Intrexon Corp1.96%
CPHD Cepheid1.94%
LGND Ligand Pharmaceuticals Inc1.94%
BIIB Biogen1.93%
CELG Celgene1.86%
MYGN Myriad Genetics Inc1.85%
AMAG AMAG Pharmaceuticals Inc1.71%

Partner Offers